Argatroban 50 mg/50mL (Argatroban INJECTION) 50 mg/50mL

Argatroban 50 mg/50mL is an injectable medication used for anticoagulation. This intravenous solution is designed to help manage blood clotting conditions. Learn more about Argatroban's uses and effects.

Strength

50 mg/50mL

Pack Size

1 VIAL in 1 CARTON (0143-9377-01) / 50 mL in 1 VIAL

Manufacturer / TM Owner

Hikma Pharmaceuticals USA Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Argatroban 50 mg/50mL is primarily used for anticoagulation, helping to prevent blood clots in certain medical conditions. It is often administered intravenously to manage clotting issues. What is Argatroban used for? This medication is typically utilized in situations where other anticoagulants may not be suitable.

Side Effects

Common effects of Argatroban may include changes in blood clotting times. Patients may experience bruising or bleeding more easily. It is important to monitor for any unusual bleeding or signs of clotting issues while using this medication.

Precautions & Warnings

Argatroban should be handled with care, as it is a potent anticoagulant. It is essential to follow medical guidance for administration and monitoring. Patients should be aware of the signs of excessive bleeding and report any concerns to their healthcare provider.

Avoid Interactions

Argatroban may interact with other anticoagulants, antiplatelet drugs, and certain medications that affect liver enzymes. Alcohol and other substances that thin the blood should be avoided to prevent increased bleeding risks.

Frequently Asked Questions

Argatroban is used for anticoagulation, helping to prevent blood clots in certain medical conditions.

Argatroban is administered intravenously, typically in a clinical setting.

Common side effects may include bruising, bleeding more easily, and changes in blood clotting times.

Argatroban may interact with other anticoagulants, antiplatelet drugs, and certain liver enzyme-affecting medications.

Patients should be monitored for signs of excessive bleeding and follow medical guidance for administration.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.